Centenial Surgical Suture Ltd. has formally raised concerns with the BSE regarding abnormal price falls and suspected manipulative trading in its shares. The company highlighted an instance where only one share was traded at Rs. 71.25, deeming the activity unnatural and pre-meditated. They are urging for an urgent investigation to address potential misuse and unethical trades, aiming to protect shareholder interests.
Allegations of Market Manipulation
Centenial Surgical Suture Ltd. has alerted the Bombay Stock Exchange (BSE) to a significant and unexplained fall in its share price, suspecting manipulative trading activities. In a letter dated October 19, 2026, the company detailed observed unusual trades, including a single equity share trading at Rs. 71.25 on that day. This event is considered part of a pattern of frequent abnormal price movements.
Call for Urgent Investigation
The company asserts that these price movements are not supported by any corporate announcements or changes in business activities, labeling the situation as ‘certainly pre-meditated’. Centenial Surgical Suture Ltd. is requesting urgent attention to investigate potential misuse, unethical, or unusual trades within its scrip. They express hope that no fraudulent individuals are involved and implore authorities to apprehend the offenders.
Company’s Stance and Request
Centenial Surgical Suture Ltd. has provided details of trades and price movements, suggesting that the observed fall and trading patterns indicate possible price rigging. The company emphasizes that it has made no material announcements that would justify such price volatility. They are seeking a thorough investigation into the unusual trading pattern, believing that certain parties are attempting to manipulate the company’s share price for vested interests. The company and its promoters have declared their readiness to assist in any investigation into potential violations of securities laws.
Reinforcing Non-Involvement
The company reiterates that neither the Company, its Promoters, Directors, nor its associates have any role in the alleged misuse, unethical, or illegal activities. They urge for prompt penal actions against any implicated broking houses or clients involved in these operations, treating the matter as an emergency to protect shareholder interests and the company’s reputation.
Source: BSE
